N
Nikhil R. Thiruvengadam
Researcher at University of California, San Francisco
Publications - 14
Citations - 160
Nikhil R. Thiruvengadam is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Pancreatitis & Randomized controlled trial. The author has an hindex of 4, co-authored 14 publications receiving 109 citations. Previous affiliations of Nikhil R. Thiruvengadam include Loma Linda University & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography
Nikhil R. Thiruvengadam,Kimberly A. Forde,Gene K. Ma,Nuzhat A. Ahmad,Vinay Chandrasekhara,Gregory G. Ginsberg,Immanuel Ho,David L. Jaffe,Kashyap Panganamamula,Michael L. Kochman,Michael L. Kochman +10 more
TL;DR: In a large retrospective cohort study of patients undergoing ERCP that included low-risk patients and patients with malignant biliary obstruction, rectal indomethacin was associated with a significant decrease in the absolute rate and severity of pancreatitis.
Journal ArticleDOI
Comparing American Gastroenterological Association Pancreatic Cyst Management Guidelines with Fukuoka Consensus Guidelines as Predictors of Advanced Neoplasia in Patients with Suspected Pancreatic Cystic Neoplasms
Gene K. Ma,David S. Goldberg,Nikhil R. Thiruvengadam,Vinay Chandrasekhara,Michael L. Kochman,Gregory G. Ginsberg,Charles M. Vollmer,Nuzhat A. Ahmad +7 more
TL;DR: The AGA guidelines are not superior to the Fukuoka guidelines in identifying AN in suspected PCNs, and both sets of guidelines have fair PPV for detection of AN, which would lead to avoidable resections in patients without AN.
Journal ArticleDOI
Emerging Therapies to Prevent Post-ERCP Pancreatitis.
TL;DR: Rectal indomethacin reduces the risk of pancreatitis in low- and average-risk patients, who comprise the majority of patients undergoing ERCP, and tacrolimus is a promising potential agent to prevent PEP.
Journal ArticleDOI
Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation.
Nikhil R. Thiruvengadam,Nikhil R. Thiruvengadam,Kimberly A. Forde,Vinay Chandrasekhara,Nuzhat A. Ahmad,Gregory G. Ginsberg,Vandana Khungar,Michael L. Kochman +7 more
TL;DR: In a retrospective study of patients who underwent ERCP for biliary complications after liver transplantation, trough levels of tacrolimus above 2.5 ng/mL are found to significantly reduce risk for PEP, and Administration of both drugs prevented patients from developing moderate or severe pancreatitis.
Journal ArticleDOI
The Pancreatitis Activity Scoring System Predicts Clinical Outcomes in Patients With Infected Pancreatic Necrosis.
TL;DR: In this paper, the authors evaluated the role of pancreatitis activity scoring system (PASS) in IPN and found that a 72-hour postintervention PASS greater than 250 was associated with post-intervention multiorgan failure (MOF) and early readmission (within 30 days).